Sei Investments Co. Sells 51,658 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sei Investments Co. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.0% in the fourth quarter, Holdings Channel reports. The fund owned 418,637 shares of the healthcare conglomerate’s stock after selling 51,658 shares during the quarter. Sei Investments Co.’s holdings in UnitedHealth Group were worth $211,775,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Plancorp LLC raised its position in shares of UnitedHealth Group by 15.4% during the fourth quarter. Plancorp LLC now owns 12,805 shares of the healthcare conglomerate’s stock valued at $6,478,000 after buying an additional 1,711 shares during the last quarter. Runnymede Capital Advisors Inc. acquired a new position in UnitedHealth Group in the fourth quarter worth about $70,000. Cyrus J. Lawrence LLC raised its position in UnitedHealth Group by 5.2% in the fourth quarter. Cyrus J. Lawrence LLC now owns 611 shares of the healthcare conglomerate’s stock worth $309,000 after purchasing an additional 30 shares in the last quarter. Mizuho Securities USA LLC raised its position in UnitedHealth Group by 45.7% in the fourth quarter. Mizuho Securities USA LLC now owns 87,222 shares of the healthcare conglomerate’s stock worth $44,122,000 after purchasing an additional 27,343 shares in the last quarter. Finally, ZEGA Investments LLC acquired a new position in UnitedHealth Group in the fourth quarter worth about $5,358,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 1.3 %

UNH opened at $517.72 on Friday. The firm’s fifty day moving average is $510.19 and its two-hundred day moving average is $547.47. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $473.57 billion, a PE ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the business posted $5.83 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.